These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23582061)

  • 21. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
    Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
    Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting RORγt and STAT3.
    Zhu E; Wang X; Zheng B; Wang Q; Hao J; Chen S; Zhao Q; Zhao L; Wu Z; Yin Z
    J Immunol; 2014 Jun; 192(12):5599-609. PubMed ID: 24842756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adiponectin Suppresses T Helper 17 Cell Differentiation and Limits Autoimmune CNS Inflammation via the SIRT1/PPARγ/RORγt Pathway.
    Zhang K; Guo Y; Ge Z; Zhang Z; Da Y; Li W; Zhang Z; Xue Z; Li Y; Ren Y; Jia L; Chan KH; Yang F; Yan J; Yao Z; Xu A; Zhang R
    Mol Neurobiol; 2017 Sep; 54(7):4908-4920. PubMed ID: 27514756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice.
    Sun Y; Tian T; Gao J; Liu X; Hou H; Cao R; Li B; Quan M; Guo L
    J Neuroimmunol; 2016 Mar; 292():58-67. PubMed ID: 26943960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute-phase protein hemopexin is a negative regulator of Th17 response and experimental autoimmune encephalomyelitis development.
    Rolla S; Ingoglia G; Bardina V; Silengo L; Altruda F; Novelli F; Tolosano E
    J Immunol; 2013 Dec; 191(11):5451-9. PubMed ID: 24154625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapamycin Ameliorates Experimental Autoimmune Encephalomyelitis by Suppressing the mTOR-STAT3 Pathway.
    Hou H; Miao J; Cao R; Han M; Sun Y; Liu X; Guo L
    Neurochem Res; 2017 Oct; 42(10):2831-2840. PubMed ID: 28600752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The therapeutic potential of ginkgolide K in experimental autoimmune encephalomyelitis via peripheral immunomodulation.
    Yu WB; Wang Q; Chen S; Cao L; Tang J; Ma CG; Xiao W; Xiao BG
    Int Immunopharmacol; 2019 May; 70():284-294. PubMed ID: 30851709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis.
    Bravo B; Gallego MI; Flores AI; Bornstein R; Puente-Bedia A; Hernández J; de la Torre P; García-Zaragoza E; Perez-Tavarez R; Grande J; Ballester A; Ballester S
    Stem Cell Res Ther; 2016 Mar; 7():43. PubMed ID: 26987803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of lncRNA-1700040D17Rik in Th17 cell differentiation and the pathogenesis of EAE.
    Guo W; Lei W; Yu D; Ge Y; Chen Y; Xue W; Li Q; Li S; Gao X; Yao W
    Int Immunopharmacol; 2017 Jun; 47():141-149. PubMed ID: 28395256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell Function.
    Kaufmann U; Shaw PJ; Kozhaya L; Subramanian R; Gaida K; Unutmaz D; McBride HJ; Feske S
    J Immunol; 2016 Jan; 196(2):573-85. PubMed ID: 26673135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Bu Shen Yi Sui Capsule on Th17/Treg cytokines in C57BL/6 mice with experimental autoimmune encephalomyelitis.
    Zheng Q; Yang T; Fang L; Liu L; Liu H; Zhao H; Zhao Y; Guo H; Fan Y; Wang L
    BMC Complement Altern Med; 2015 Mar; 15():60. PubMed ID: 25887665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.
    Aggelakopoulou M; Kourepini E; Paschalidis N; Panoutsakopoulou V
    J Immunol; 2016 Jun; 196(12):4947-56. PubMed ID: 27183630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The NF-κB transcription factor c-Rel is required for Th17 effector cell development in experimental autoimmune encephalomyelitis.
    Chen G; Hardy K; Pagler E; Ma L; Lee S; Gerondakis S; Daley S; Shannon MF
    J Immunol; 2011 Nov; 187(9):4483-91. PubMed ID: 21940679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.
    Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH
    Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barré syndrome as well as their animal models.
    Wang X; Ma C; Wu J; Zhu J
    J Neurosci Res; 2013 Jul; 91(7):871-81. PubMed ID: 23653308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of
    Zhou Y; Leng X; He Y; Li Y; Liu Y; Liu Y; Zou Q; Shi G; Wang Y
    Front Immunol; 2018; 9():842. PubMed ID: 29740445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,25-dihydroxyvitamin D
    Xie Z; Chen J; Zheng C; Wu J; Cheng Y; Zhu S; Lin C; Cao Q; Zhu J; Jin T
    Immunology; 2017 Nov; 152(3):414-424. PubMed ID: 28617989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
    Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
    Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-485 regulates Th17 generation and pathogenesis in experimental autoimmune encephalomyelitis through targeting STAT3.
    Xue Y; Zhang L; Guo R; Shao X; Shi M; Yuan C; Li X; Li B
    J Neuroimmunol; 2023 Jun; 379():578100. PubMed ID: 37187004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Th17 Cells in MS and Experimental Autoimmune Encephalomyelitis.
    Hofstetter H; Gold R; Hartung HP
    Int MS J; 2009 Apr; 16(1):12-8. PubMed ID: 19413921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.